Through a comprehensive analysis of the results of histological and cytological experiments, we found that the expression of SLC27A1 was significantly high in aggressive pituitary adenomas and TMZ therapy sensitive cell lines, while the expression of PTBP1 and EIF5A was significantly decreased. Here, EIF5A is linked to pituitary gland adenoma.